These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 22306793
1. Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain. Napier IA, Klimis H, Rycroft BK, Jin AH, Alewood PF, Motin L, Adams DJ, Christie MJ. Neuropharmacology; 2012 Jun; 62(7):2202-7. PubMed ID: 22306793 [Abstract] [Full Text] [Related]
2. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain. Klimis H, Adams DJ, Callaghan B, Nevin S, Alewood PF, Vaughan CW, Mozar CA, Christie MJ. Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259 [Abstract] [Full Text] [Related]
3. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Nevin ST, Clark RJ, Klimis H, Christie MJ, Craik DJ, Adams DJ. Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600 [Abstract] [Full Text] [Related]
5. Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB. Wu X, Tae HS, Huang YH, Adams DJ, Craik DJ, Kaas Q. Biochem Pharmacol; 2018 Sep 01; 155():288-297. PubMed ID: 30009767 [Abstract] [Full Text] [Related]
6. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors. Dutertre S, Nicke A, Tyndall JD, Lewis RJ. J Mol Recognit; 2004 Sep 01; 17(4):339-47. PubMed ID: 15227641 [Abstract] [Full Text] [Related]
7. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit. Beissner M, Dutertre S, Schemm R, Danker T, Sporning A, Grubmüller H, Nicke A. Mol Pharmacol; 2012 Oct 01; 82(4):711-8. PubMed ID: 22802270 [Abstract] [Full Text] [Related]
8. Alpha-conotoxin analogs with enhanced affinity for nicotinic receptors and acetylcholine-binding proteins. Tsetlin VI, Kasheverov IE, Zhmak MN, Utkin YN, Vulfius CA, Smit AB, Bertrand D. J Mol Neurosci; 2006 Oct 01; 30(1-2):77-8. PubMed ID: 17192636 [Abstract] [Full Text] [Related]
9. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? Mohammadi SA, Christie MJ. Toxins (Basel); 2015 Sep 28; 7(10):3916-32. PubMed ID: 26426047 [Abstract] [Full Text] [Related]
11. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors. Kasheverov IE, Zhmak MN, Vulfius CA, Gorbacheva EV, Mordvintsev DY, Utkin YN, van Elk R, Smit AB, Tsetlin VI. FEBS J; 2006 Oct 28; 273(19):4470-81. PubMed ID: 16956365 [Abstract] [Full Text] [Related]
12. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor. Yu R, Kompella SN, Adams DJ, Craik DJ, Kaas Q. J Med Chem; 2013 May 09; 56(9):3557-67. PubMed ID: 23566299 [Abstract] [Full Text] [Related]
13. Spinal alpha3beta2* nicotinic acetylcholine receptors tonically inhibit the transmission of nociceptive mechanical stimuli. Young T, Wittenauer S, McIntosh JM, Vincler M. Brain Res; 2008 Sep 10; 1229():118-24. PubMed ID: 18634758 [Abstract] [Full Text] [Related]
14. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1. Indurthi DC, Pera E, Kim HL, Chu C, McLeod MD, McIntosh JM, Absalom NL, Chebib M. Biochem Pharmacol; 2014 May 01; 89(1):131-40. PubMed ID: 24548457 [Abstract] [Full Text] [Related]
15. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors. Liang J, Tae HS, Xu X, Jiang T, Adams DJ, Yu R. J Med Chem; 2020 Mar 26; 63(6):2974-2985. PubMed ID: 32101438 [Abstract] [Full Text] [Related]
16. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Satkunanathan N, Livett B, Gayler K, Sandall D, Down J, Khalil Z. Brain Res; 2005 Oct 19; 1059(2):149-58. PubMed ID: 16182258 [Abstract] [Full Text] [Related]
17. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels. Daly NL, Callaghan B, Clark RJ, Nevin ST, Adams DJ, Craik DJ. J Biol Chem; 2011 Mar 25; 286(12):10233-7. PubMed ID: 21252227 [Abstract] [Full Text] [Related]
18. Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus. Fu Y, Matta SG, McIntosh JM, Sharp BM. Neurosci Lett; 1999 May 07; 266(2):113-6. PubMed ID: 10353340 [Abstract] [Full Text] [Related]
19. Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. Nicke A, Wonnacott S, Lewis RJ. Eur J Biochem; 2004 Jun 07; 271(12):2305-19. PubMed ID: 15182346 [Abstract] [Full Text] [Related]
20. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions. Li R, Li X, Jiang J, Tian Y, Liu D, Zhangsun D, Fu Y, Wu Y, Luo S. J Mol Graph Model; 2019 Nov 07; 92():55-64. PubMed ID: 31330438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]